Efficacy of the Nanodropper Device on Pupillary Dilation

Dilation Clinical Trial

Official title:
Efficacy of the Nanodropper Device on Pupillary Dilation

Status Completed

Clinical Trial Summary

Prescription eye drop bottles elute drops that exceed the capacity of the human eye by five times. This study describes performing in clinic dilation using a novel solution for combating medical waste with Nanodropper, an eye drop bottle adapter that creates smaller eye drops.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05274321
Study type	Interventional
Source	University of California, San Francisco
Contact
Status	Completed
Phase	N/A
Start date	July 29, 2021
Completion date	November 19, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05134974` - Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis (MIRA-3)	Phase 3
Completed	`NCT04620213` - Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis	Phase 3
Not yet recruiting	`NCT06366217` - Efficacy of the MydCombi on Pupillary Dilation in Pediatric and Adult Patients	Phase 4
Completed	`NCT05223478` - Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis in Pediatric Subjects	Phase 3
Completed	`NCT04024891` - Safety and Efficacy of Ophthalmic Phentolamine Mesylate to Reverse Pharmacologically Induced Mydriasis	Phase 2